JERSEY CITY, N.J., Dec. 10, 2021 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced virtual poster presentations reviewing the Phase 4 REFINE-ALS biomarker study in people ...
Study Results May Help to Identify Monitoring Biomarkers of ALS as well as Predictive Biomarkers to Measure the Effect of RADICAVA ® (edaravone) JERSEY CITY, N.J., Nov. 2, 2022 /PRNewswire/ -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results